查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
2022-2029 年全球鼻窦扩张器市场
市场调查报告书
商品编码
1153817

2022-2029 年全球鼻窦扩张器市场

Global Sinus Dilation Devices Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 200 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概览

全球鼻窦扩张器市场预计 2021 年将达到 351643 万美元，2029 年将达到 498372 万美元，预测期（2022-2029 年）的复合年增长率为 5.07%。

鼻窦感染伴有鼻道和鼻窦肿胀，也称为鼻窦炎。鼻窦扩张器用于鼻窦疾病的手术治疗。鼻窦扩张器由于在鼻窦疾病的手术治疗中的应用，在慢性鼻窦炎患者中取得了良好的效果，近年来越来越受欢迎。慢性鼻窦炎是世界范围内的一个主要问题。

市场动态

慢性鼻窦炎患病率上升、医用扩张器的监管批准增加、微创手术的采用以及持续的研究和开发将在预测期内推动全球鼻窦扩张器市场。

不断推出新产品和加大研发力度推动市场增长。

全球鼻窦扩张器市场的主要驱动因素是慢性鼻窦炎的高患病率和对微创手术的日益偏好。此外，新兴国家庞大的医疗费用补贴制度也是市场扩张的一个因素。

鼻窦炎治疗技术的进步以及球囊鼻窦扩张术相对于传统手术的优势促进了全球鼻窦扩张器市场的发展。例如，2022 年 2 月，医疗技术公司美敦力公司推出了一款名为 NuVent 的新型咽鼓管扩张球囊，该球囊获得了美国 FDA 的批准。 NuVent 帮助外科医生在适当的办公室或门诊环境中提供治疗。球囊可以根据患者的解剖结构定制放置。

各种资金、新技术进步以及越来越多的最新创新产品发布导致对鼻窦扩张设备的高需求。例如，2021 年 9 月，设计微创耳鼻喉技术的强生医疗器械子公司 Acclarent Inc 宣布了一项人工智能驱动的耳鼻喉技术，该技术可简化手术计划并在耳鼻喉导航过程中提供反馈。该软件将 TruPath 和 TruSeg 与 TruDi 导航系统相结合，为内窥镜鼻窦手术等耳鼻喉手术提供高效的图像引导导航和规划。

替代品的存在以及与窦扩张器相关的高成本阻碍了市场增长。

然而，与鼻窦扩张器相关的高成本以及对使用鼻窦药物进行鼻窦手术的低偏好可能会阻碍市场的发展。非处方药占了大部分费用，但对大多数慢性鼻窦炎患者的益处微乎其微。

COVID-19 影响分析

疫情对全球金融预测、运营和危机应对策略产生了负面影响。 COVID-19 的爆发严重影响了医疗保健行业。由于对 COVID 的关注，所有研究和临床试验都受到影响，因此窦扩张器市场遭受了巨大损失。然而，市场进入者现在正在通过利用研究市场和创造尖端项目来对抗这种流行病，从而改变他们的长期和短期增长战略。世界各地正在发生各种倡议、合作和合併，促进了市场的增长。例如，2020 年 7 月，专有内窥镜製造商 Optim LLC 宣布与 MedShare 合作，将其 ENTity 鼻咽镜捐赠给世界各地的贫困社区。

内容

第 1 章市场研究方法和范围

  • 调查方法
  • 调查目的和范围

第 2 章市场定义和概述

第 3 章执行摘要

第四章市场动态

  • 市场影响因素
    • 司机
      • 新产品发布次数增加
      • 增加研发
    • 约束因素
      • 市场上可用的替代品
    • 商机
    • 影响分析

第五章行业分析

  • 波特五力模型
  • 未满足的需求
  • 供应链分析
  • 监管分析

第 6 章 COVID-19 分析

  • COVID-19 市场分析
    • COVID-19 之前的市场情景
    • COVID-19 的当前市场情景
    • COVID-19 后或未来情景
  • COVID-19 期间的价格动态
  • 供需范围
  • 大流行期间与市场相关的政府举措
  • 製造商的战略举措
  • 总结

第 7 章副产品

  • 球囊窦扩张器
  • 窦镜
  • 鼻窥器
  • 手持设备
  • 鼻窦支架

第八章治疗类型

  • 独立的窦扩张
  • 混合窦扩张

第 9 章最终用户

  • 医院
  • 门诊手术中心
  • 耳鼻喉科诊所
  • 其他

第10章按地区

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲

第11章竞争格局

  • 主要发展和战略
  • 公司股票分析
  • 产品基准
  • 值得关注的主要公司名单

第12章公司简介

  • Medtronic Plc
    • 公司简介
    • 产品组合和说明
    • 主要亮点
    • 财务摘要
  • Smith and Nephew Plc
  • Acclarent, Inc.
  • Stryker
  • Olympus Corporation
  • Optim LLC
  • Cook Medical
  • Summit Health Medical
  • Dalent Medical
  • Meril Life Sciences

第13章 鼻窦扩张器世界市场-DataM

简介目录
Product Code: DMMD883

Market Overview

The global sinus dilation devices market was valued at US$ 3,516.43 million in 2021 and is estimated to reach US$ 4,983.72 million by 2029, growing at a CAGR of 5.07% during the forecast period (2022-2029).

Sinus infection involves swelling of nasal passages or sinuses, also known as sinusitis. Sinus dilation devices are used in the surgical treatment of sinus disease. The satisfactory results of these devices in patients with chronic sinusitis have increased their adoption in recent years. Chronic sinusitis and related conditions are a dominant medical problem worldwide.

Market Dynamics

Increased prevalence of chronic sinusitis, increased regulatory approval of medical dilation devices, adoption of minimally invasive surgery, and ongoing research and development activities are driving the global sinus dilation devices market during the forecast period.

The increasing number of novel product launches and the rising research and development will drive market growth.

The global market for sinus dilation devices is primarily driven by the high prevalence of chronic sinusitis and a growing preference for minimally invasive surgeries. Other factors aiding the market growth are favorable reimbursement scenarios growing the healthcare market in emerging economies.

Technological advancements in sinusitis treatments and the benefits of balloon sinus dilation over conventional operations contribute to the global sinus dilation devices market. For instance, in Feb 2022, Medtronic Plc, a healthcare technology company, launched its novel Eustachian tube dilation balloon named NuVent, approved by the U.S. FDA. NuVent helps surgeons deliver appropriate office or outpatient setting treatment. The flexible balloon section can be customized for placement based on a patient's anatomy.

Various funding, novel technological advancements, and the number of the latest, innovative product launches are increasing, leading to the high demand for sinus dilation devices. For instance, in Sep 2021, Acclarent Inc, Johnson & Johnson Medical Device Subsidiary, which designs minimally invasive ENT technologies, launched its AI-powered ENT technology that will simplify surgical planning and, during ENT navigation procedures, will give feedback. This software will use TruPath and TruSeg with the TruDi navigation system and provide efficient image-guided navigation and planning for ENT surgeries such as endoscopic sinus surgery.

The presence of alternatives and high costs associated with sinus dilation devices will hamper the market's growth.

However, high costs associated with sinus dilation device equipment and the low preference for sinus surgical procedures due to sinusitis drugs may hinder market progress. Over-the-counter drugs account for much of the expense yet provide minimal benefit in most patients with chronic sinusitis.

COVID-19 Impact Analysis

The pandemic has negatively impacted global financial expectations, operations and crisis response strategy. The COVID-19 outbreak has severely impacted the healthcare industry. The sinus dilation devices market has experienced huge losses due to COVID, as all the research and clinical trials got affected due to the diversion of attention toward COVID. But now, the market participants are changing their long-term and short-term growth strategies by utilizing the research market and creating cutting-edge items to combat the pandemic. Various initiatives, collaborations and mergers are happening worldwide, boosting the market's growth. For instance, in Jul 2020, Optim LLC, a proprietary endoscopes manufacturer, announced its partnership with MedShare for donating its ENTity Nasopharyngoscopes to under-served communities globally.

Segment Analysis

The balloon sinus dilation devices are expected to grow at the fastest CAGR during the forecast period (2022-2029)

Balloon sinus dilation devices are the highest market holder in the global sinus dilation devices market. Balloon sinus dilation is a procedure in which, under endoscopic visualization, a flexible balloon catheter is inserted into the sinus passages blocked by an ENT surgeon. After the balloon placement, it is inflated to open the sinus cavity. To flush out pus or mucus, they inject a saline solution. This reduces the trauma caused to delicate tissues in the passage. After the drainage of fluid, the patient feels relieved.

The balloon sinus dilation device segment dominates the market due to the demand for these devices and rising global sinusitis infection cases. The growing number of regulatory approvals, technological advancements, product launches, and research/clinical trial studies drive the market's growth. For instance, in May 2022, Dalent Medical, a medical technology company that designs innovative devices for sinus treatment, acquired a new patent in its intellectual property portfolio. This patent protects the Sinusleeve balloon, Dalen's proprietary balloon sinus dilation device for chronic sinusitis treatment.

Geographical Analysis

North America holds the largest market share of the global sinus dilation devices market.

North America dominates the global sinus dilation devices market, primarily attributed to the increase in the prevalence of chronic sinusitis, increase in pharmaceutical establishment across the region and government approvals, increase in adoption of minimally invasive surgical procedures in recent years, and presence of key players in the region are contributing to the growth of sinus dilation devices market. According to the Sinus and Allergy Wellness Centre report 2021, Sinusitis affects approximately 30 million adults, about 11.6% of the adult population in the United States.

Moreover, the growing number of product launches is responsible for the market's growth. Many key developments, technological advancements, collaborations and agreements are taking place in this region. For instance, in Aug 2022, Acclarent Inc, Johnson & Johnson Medical Device Subsidiary, which designs minimally invasive ENT technologies, announced that its TruDi shaver blade, a single-use electromagnetically navigated blade, got clearance from U.S. Food and Drug Administration. TruDi can be used for the removal or incision of tissues or bones in ENT.

Competitive Landscape

The sinus dilation devices market is moderately competitive with local and global companies' presence. Medtronic Plc, Smith and Nephew Plc, Acclarent, Inc., Stryker, Olympus Corporation, Optim LLC, Cook Medical, Summit Health Medical, Dalent Medical, Meril Life Sciences and more. The key players are adopting various growth strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, contributing to the market's growth. For instance, in Feb 2022, Olympus, an innovative solution developer for surgical and medical procedures, announced that its single-use sinus debrider system CELERIS received clearance from the U.S. Food and Drug Administration.

Medtronic Inc.:

Overview:

Medtronic plc is a healthcare technology company that develops, manufactures and markets medical devices. It was established in 1949 and is headquartered in Dublin, Ireland. It is operational in around 140 countries, and 90,000 people are employed there.

Product Portfolio:

NuVent EM Sinus Dilation System: NuVent balloon dilation is a targeted system used for balloon sinus surgery with a built-in electromagnetic surgical navigation technology. It provides a different and unique addition to sinus surgery treatment.

Key Development: In May 2022, Medtronic Plc, a healthcare technology company, announced the completion of the acquisition of Intersect ENT. This acquisition will help Medtronic expand its ENT portfolio in sinus procedures for nasal polyps treatment.

The global sinus dilation devices market report would provide access to approximately 40+ market data tables, 45+ figures, and 200 (approximate) pages.

Table of Contents

1. Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. The rising novel product launches
      • 4.1.1.2. Increasing research and development
    • 4.1.2. Restraints:
      • 4.1.2.1. Alternatives available in market
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces
  • 5.2. Unmet Needs
  • 5.3. Supply chain Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Product

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 7.1.2. Market Attractiveness Index, By Product
  • 7.2. Balloon Sinus Dilation Devices*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Sinuscopes
  • 7.4. Rhinoscopes
  • 7.5. Handheld Instruments
  • 7.6. Sinus Stents

8. By Procedure Type

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure Type
    • 8.1.2. Market Attractiveness Index, By Procedure Type
  • 8.2. Standalone Sinus Dilation *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Hybrid Sinus Dilation

9. By End-User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By End-User
    • 9.1.2. Market Attractiveness Index, By End-User
  • 9.2. Hospitals *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Ambulatory Surgical Centres
  • 9.4. ENT Clinics
  • 9.5. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure Type
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), End-User
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. The U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure Type
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), End-User
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. The U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure Type
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), End-User
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure Type
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), End-User
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure Type
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), End-User
    • 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country

11. Competitive Landscape

  • 11.1. Key Developments and Strategies
  • 11.2. Company Share Analysis
  • 11.3. Product Benchmarking
  • 11.4. List of Key Companies to Watch

12. Company Profiles

  • 12.1. Medtronic Plc
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. Smith and Nephew Plc
  • 12.3. Acclarent, Inc.
  • 12.4. Stryker
  • 12.5. Olympus Corporation
  • 12.6. Optim LLC
  • 12.7. Cook Medical
  • 12.8. Summit Health Medical
  • 12.9. Dalent Medical
  • 12.10. Meril Life Sciences

LIST NOT EXHAUSTIVE

13. Global Sinus Dilation Devices Market- DataM

  • 13.1. Appendix
  • 13.2. About Us and Services
  • 13.3. Contact Us